Medigen Vaccine Biologics
Taiwan - Taipei
BiotechnologyFocus: Vaccines, Biologics
Medigen Vaccine Biologics is a life sciences company focused on Vaccines, Biologics.
Infectious DiseasesVaccines
Open Jobs
0
Pipeline & Clinical Trials
EV71 vaccine
Enterovirus 71 HumanClinical Trials (1)
NCT04072276Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children
N/AMVC-COV1901
COVID-19 VaccineClinical Trials (1)
NCT05216601A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19
Phase 1MVC-COV1901
COVID-19Clinical Trials (1)
NCT04487210A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19
Phase 1AT-501 High Dose vaccine
H7N9 Influenza VaccineClinical Trials (1)
NCT02436928A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects
Phase 1/2BNT162b2
COVID-19Clinical Trials (1)
NCT05132855The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
Phase 1/2MVC-COV1901
Covid19 VaccineClinical Trials (1)
NCT04951388A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents
Phase 2MVC-COV1901
Covid19 VaccineClinical Trials (1)
NCT04695652A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
Phase 2MVC-COV1901
Covid19 VaccineClinical Trials (1)
NCT05038618A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study
Phase 2TV003
DengueClinical Trials (1)
NCT03485144A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan
Phase 2MVC-COV1901
Covid19 VaccineClinical Trials (1)
NCT05048849A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study
Phase 2Half dose of MVC-COV1901
COVID-19 VaccineClinical Trials (1)
NCT05197153A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19
Phase 2EV71 with adjuvant aluminium phosphate
Enterovirus 71 HumanClinical Trials (1)
NCT02200237A Clinical Study for Inactivated Vaccine Against EV71
Phase 2MVC-COV1901
Covid19 VaccineClinical Trials (1)
NCT04822025A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults
Phase 2MVC-COV1901
Covid19 VaccineClinical Trials (1)
NCT05011526A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults
Phase 3Envacgen®
Enterovirus 71 Inactivated VaccineClinical Trials (1)
NCT07178522A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years
Phase 3GC FLU Quadrivalent
InfluenzaClinical Trials (1)
NCT03718468A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine
Phase 3MVC-COV1901
COVID-19 VaccineClinical Trials (1)
NCT05426343A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222
Phase 3MVC-COV1901
COVID-19 VaccineClinical Trials (1)
NCT05198596A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
Phase 3EV71vac
Enterovirus 71 InfectionClinical Trials (1)
NCT03865238A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine
Phase 3MVC-COV1901
COVID-19 VaccineClinical Trials (1)
NCT05097053A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2021
Portfolio: 20 clinical trials